CEGIR is a multifaceted, collaborative effort between academic medical centers, NIH scientists, and patient advocacy groups, who help ensure the needs of the patients are recognized and met. CEGIR focuses on research projects involving patients with eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), and/or eosinophilic colitis (EC). Learn more about the clinical studies that CEGIR is conducting:
A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular, and Patient-Reported Outcomes in Pediatric and Adult Patients with Eosinophilic Esophagitis (EoE), Gastritis (EG) and Colitis (EC)
Six Food vs One Food Eosinophilic Esophagitis Elimination Diet followed by Swallowed Glucocorticoid Trial
Effect of Elemental Diet on Adult Patients with Eosinophilic Gastroenteritis
|Eosinophilic Esophagitis (EoE) Intervention Trial-Randomized 1 Food Elimination vs. 4 Food Elimination Diet followed by Swallowed Glucocorticoids
|CEGIR OMEGA Study Information||CEGIR SOFEED Study Information||CEGIR ELEMENT Study Information||CEGIR Study Information|
|Flyer to share:|
Have you seen the summer issue of the RDCRN-CEGIR Contact Registry newsletter? It describes projects currently underway by the Consortium. To subscribe to these newsletters, follow the links in the PDF to enroll in the Registry.